BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29708630)

  • 21. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
    Ge J; Zheng J; Zhang L; Yuan W; Zhao H
    Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds.
    Chan H; McKay C; Adams S; Wargon O
    Pediatrics; 2013 Jun; 131(6):e1739-47. PubMed ID: 23650294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis.
    Khan M; Boyce A; Prieto-Merino D; Svensson Å; Wedgeworth E; Flohr C
    Acta Derm Venereol; 2017 Nov; 97(10):1167-1171. PubMed ID: 28421234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
    Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
    Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangiomas.
    Anwar F; Mahmood E; Sharif S; Shah R; Jamgochian M; Ouellette S; Umar M; Rao B
    J Drugs Dermatol; 2023 Jun; 22(6):594-598. PubMed ID: 37276157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
    Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
    Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
    Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
    Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.
    Hu L; Huang HZ; Li X; Lin XX; Li W
    Dermatology; 2015; 230(2):150-5. PubMed ID: 25633200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma.
    He L; Huang G
    J Clin Ultrasound; 2017 Oct; 45(8):480-487. PubMed ID: 28369943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.
    Chakkittakandiyil A; Phillips R; Frieden IJ; Siegfried E; Lara-Corrales I; Lam J; Bergmann J; Bekhor P; Poorsattar S; Pope E
    Pediatr Dermatol; 2012; 29(1):28-31. PubMed ID: 22150436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
    Sorrell J; Chamlin SL
    Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
    Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
    JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Usage and efficacy of timolol maleate eye drops in treatment of superficial infantile hemangioma].
    Wu Q; Shi Q; Long J; Li J; Guo Y; Lei S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):657-661. PubMed ID: 28690223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
    Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
    Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH).
    Boos MD; Castelo-Soccio L
    J Am Acad Dermatol; 2016 Mar; 74(3):567-70. PubMed ID: 26892656
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
    Marey HM; Elmazar HF; Mandour SS; Khairy HA
    J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
    Ho NT; Lansang P; Pope E
    J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infantile Hemangioma: An Updated Review.
    Leung AKC; Lam JM; Leong KF; Hon KL
    Curr Pediatr Rev; 2021; 17(1):55-69. PubMed ID: 32384034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Episcleral infantile hemangioma successfully treated with topical timolol.
    Ciudad Blanco C; Campos Domínguez M; Moreno García B; Villanueva Álvarez-Santullano CA; Berenguer Fröhner B; Suárez Fernández R
    Dermatol Ther; 2015; 28(1):22-4. PubMed ID: 25286087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.